Skip to main content
G

Genomma Lab Internacional, S.A.B. de C.V. — Investor Relations & Filings

Ticker · LAB LEI · 984500B7084AA76ACF85 MX Manufacturing
Open in API
Filings indexed 185 across all filing types
Latest filing 2026-04-23 Regulatory Filings
Country MX Mexico
Listing MX LAB

About Genomma Lab Internacional, S.A.B. de C.V.

Genomma Lab Internacional, S.A.B. de C.V. specializes in the development, marketing, and distribution of over-the-counter (OTC) medications and personal care products. Established in 1996, the organization operates with a business model that combines pharmaceutical research with mass-market commercialization strategies. Its diverse portfolio encompasses various therapeutic categories and cosmetic segments, featuring recognized brands such as Cicatricure, Asepxia, Goicoechea, Tio Nacho, and XL-3. The company focuses on providing accessible health and wellness solutions through an extensive distribution network that reaches multiple international markets. By leveraging data-driven marketing and a robust supply chain, the entity aims to improve consumer well-being while maintaining a competitive presence in its active markets.

Recent filings

Filing Released Lang Actions
Genomma Lan Internacional Anuncia resultados del Primer Trim
Regulatory Filings
2026-04-23 Spanish
Genomma Lan Internacional Anuncia resultados del Primer Trim
Regulatory Filings
2026-04-23 Spanish
Constancia de primer trimestre 2026
Regulatory Filings Classification · 1% confidence The document is a formal letter addressed to the Comisión Nacional Bancaria y de Valores (CNBV) in Mexico. It consists of a certification statement signed by company officers regarding the 'Reporte del Primer Trimestre de 2026'. The document does not contain the actual financial statements or substantive financial data of the quarterly report itself; rather, it serves as an officer certification/attestation of the report. According to the 'Certification Rule', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS). Q1 2026
2026-04-23 Spanish
Propuesta divulgación IFRS S1 Y S2
Environmental & Social Information Classification · 1% confidence The document is a detailed disclosure aligned with IFRS S1 and S2 (sustainability reporting standards) covering governance structures, risk oversight, strategy, and metrics related to environmental and climate matters. It is lengthy (over 72,000 characters) and contains substantive ESG content rather than merely announcing or referencing another report. Therefore, it is an Environmental & Social Information filing.
2026-04-22 Spanish
AVISO DE CONTRATACIÓN DE FORMADOR DE MERCADO
Regulatory Filings
2026-04-14 Spanish
Asamblea General Anual Ordinaria 2025
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal “convocatoria” (notice) to all shareholders of Genomma Lab Internacional, S.A.B. de C.V. for its Annual General Ordinary Shareholders’ Meeting, including the full agenda and instructions on how to obtain admission cards and proxy forms. This type of filing constitutes solicitation of shareholder votes and provision of meeting information rather than the meeting results or post‐meeting materials. Therefore, it fits the definition of “Proxy Solicitation & Information Statement” (PSI).
2026-04-13 Spanish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.